Access
This article is part of Nature's premium content.
Published online 31 October 2007 | Nature 450, 17 (2007) | doi:10.1038/450017a
News in Brief: Business
Patents upheld
California biotech wins patent case.
A US jury has ruled decisively for the pharmaceutical firm Amgen in a crucial patent lawsuit, finding that a competing anaemia drug made by Swiss drugmaker Roche infringed several patents belonging to the California-based biotechnology company. After the 23 October ruling, Amgen said that it would seek an injunction to prevent Roche from marketing its drug, Mircera, in the United States.
To read this story in full you will need to login or make a payment (see right).
Comments
Reader comments are usually moderated after posting. If you find something offensive or inappropriate, you can speed this process by clicking 'Report this comment' (or, if that doesn't work for you, email webadmin@nature.com). For more controversial topics, we reserve the right to moderate before comments are published.
There are currently no comments.
